A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects with Advanced Cancer
-
- STATUS
- Not Recruiting
Updated on 19 February 2024
Summary
The purpose of this study is to find the highest dose of ABBV-075 that can be given to subjects with cancer without causing side effects.
Description
This is a Phase 1, first-in-human, dose escalation study of ABBV-075 in participants with advanced cancer to determine the maximum tolerated dose and the recommended Phase 2 dose of ABBV-075.
Details
| Condition | Breast Cancer,Non-Small Cell Lung Cancer,Acute Myeloid Leukemia,Multiple Myeloma |
|---|---|
| Age | 18years - 99years |
| Clinical Study Identifier | TX4990 |
| Last Modified on | 19 February 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.